Alma Lasers is a global developer, manufacturer and provider of lasers for aesthetic and medical applications
Shanghai Fosun Pharma, the subsidiary of Fosun International, and Pramerica-Fosun China Opportunity Fund will pay $240 million for up to 95.6% of Israel-based Alma Lasers.
It is Fosun Pharma’s first international healthcare acquisition since its Hong Kong H-share listing in October last year. According to IMS Health Incorporated, Fosun was one of the top five domestic companies in China by revenue in the pharmaceutical manufacturing segment in 2011.
China is one...